- Home
- XENE vs GNW Comparison
XENE vs GNW Comparison
Compare XENE & GNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XENE | GNW |
|---|---|---|
| Founded | 1996 | 1871 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.3B |
| IPO Year | 2014 | 2004 |
Fundamental Metrics
Financial Performance| Metric | XENE | GNW |
|---|---|---|
| Price | $55.97 | $7.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $67.25 | $10.00 |
| AVG Volume (30 Days) | 1.4M | ★ 3.2M |
| Earning Date | 05-28-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | $311,000.00 | ★ $7,301,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,823.63 | N/A |
| P/E Ratio | ★ N/A | $15.02 |
| Revenue Growth | N/A | ★ 0.08 |
| 52 Week Low | $26.74 | $5.99 |
| 52 Week High | $62.91 | $9.28 |
Technical Indicators
Market Signals| Indicator | XENE | GNW |
|---|---|---|
| Relative Strength Index (RSI) | 65.62 | 31.82 |
| Support Level | $38.36 | $6.70 |
| Resistance Level | N/A | $8.18 |
| Average True Range (ATR) | 2.41 | 0.25 |
| MACD | 1.56 | -0.06 |
| Stochastic Oscillator | 67.32 | 0.01 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About GNW Genworth Financial Inc
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. Majority of the revenue is generated by the Enact segment. The company earns maximum of its revenue in the United States.